Process Optimization Jobs in Redwood City, CA
Please select the country where you want to search for a job.
-
Job Type
-
Posting Date
5 Jobs Found | Sort By : Relevance | Posted Date
Less results matching your search!
Try removing some of the filters to get more results
No results matching your search!
Try removing some of the filters to get more results
Associate Director, Drug Substance
Revolution Medicines
Redwood City - USA
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Compa...
Associate Director, Regulatory Operations
Revolution Medicines
Redwood City - USA
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Compa...
Senior Scientist I, Drug Substance
Revolution Medicines
Redwood City - USA
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Compa...
Temp Manager, Commercialization Contracts Administ...
Revolution Medicines
Redwood City - USA
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Compa...
Director, Regulatory Operations (systems)
Revolution Medicines
Redwood City - USA
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins and RAS Compa...
